Weight gain during growth hormone (HGH) therapy is common and, in most cases, driven by fluid retention rather than fat gain. In studies of healthy adults given supraphysiological doses, body weight increased by about 2.7% within a single month, and nearly all of that increase was explained by a rise in extracellular water. Understanding which type of weight you’re gaining, and when, makes the difference between an expected side effect and a sign that something needs adjusting.
Fluid Retention Is the Most Likely Cause
Growth hormone directly increases sodium reabsorption in the kidneys, specifically in the distal part of the tubule where your body fine-tunes how much salt and water it holds onto. More sodium retained means more water follows it into your tissues. At the same time, HGH prevents the normal pressure-driven mechanism your kidneys use to flush excess sodium when blood volume rises. The result is a sustained expansion of extracellular fluid, the water that sits between and around your cells rather than inside them.
In clinical trials, extracellular water increased by roughly 9.6% in adults receiving supraphysiological HGH doses over one month. That alone can add several pounds to the scale. Up to 30% of patients on HGH therapy report fluid retention as a side effect, often accompanied by joint pain, hand numbness from carpal tunnel pressure, and general puffiness. In one pooled analysis, the observed increase in fat-free mass of 5.3% was almost entirely accounted for by the water increase, meaning the scale moved without meaningful muscle being added.
You’ll typically notice this fluid-related weight gain within the first few weeks of starting therapy. It tends to be most pronounced in the hands, feet, and ankles, and it often improves as your body adjusts or if the dose is lowered.
How HGH Changes Your Body Composition
HGH doesn’t just add water. Over time, it genuinely shifts the ratio of lean tissue to fat in your body. A meta-analysis of placebo-controlled trials in adults with growth hormone deficiency found that treated subjects gained an average of 2.6 kg (about 5.7 pounds) of lean body mass while losing about 2.2 kg (4.8 pounds) of fat. Both effects were dose-dependent: higher doses produced greater changes in each direction.
This creates a confusing situation on the scale. You may be losing fat and gaining lean tissue at roughly similar rates, which means the number barely moves, or it goes up slightly because you’re also holding extra fluid on top of the new lean mass. Harvard Health reported that subjects receiving HGH injections for an average of 20 days gained about 4.6 pounds of lean body mass while shedding a similar amount of fat. Yet despite that lean mass increase, there was no measurable improvement in strength or exercise capacity, reinforcing that much of what registers as “lean mass” on a body composition test early in therapy is really water.
The fat loss itself follows a specific pattern. Visceral fat, the deep abdominal fat surrounding your organs, drops the most dramatically. One study in men with growth hormone deficiency found a 47% reduction in intra-abdominal fat and a 27% reduction in subcutaneous fat (the fat under your skin) over six months. The subcutaneous fat loss was gradual and continued for roughly six months before plateauing. So if you’re noticing the scale creep up in the first few weeks or months, fat redistribution hasn’t had time to fully take effect yet.
Insulin Resistance and Blood Sugar Shifts
HGH has a well-documented effect on how your body handles insulin. It stimulates the breakdown of fat stores, particularly visceral fat, flooding the bloodstream with free fatty acids. Those circulating fatty acids interfere with insulin signaling in muscle and liver tissue, making your cells less responsive to insulin. Your pancreas compensates by producing more insulin, and elevated insulin levels promote energy storage.
This insulin resistance is a direct pharmacological effect of growth hormone, not a sign of something going wrong with your health per se. But it matters for weight because chronically elevated insulin can shift your metabolism toward storing calories rather than burning them, especially if your diet is high in carbohydrates. In the liver, the surge of free fatty acids also promotes fat oxidation and can lead to accumulation of certain metabolic byproducts that further blunt insulin’s ability to do its job.
If you’re gaining weight that seems like actual body fat rather than puffiness, this insulin pathway is worth investigating with bloodwork. Fasting glucose and insulin levels can reveal whether HGH is pushing your metabolism into a more storage-friendly state.
Appetite May Increase Indirectly
HGH itself doesn’t directly stimulate hunger, but the hormonal ecosystem around it does. Ghrelin, often called the hunger hormone, acts on the same receptor that growth hormone secretagogues target. Ghrelin’s appetite-stimulating effects are well established: it causes acute increases in food intake within 30 minutes of administration in animal studies, and its levels naturally rise during fasting to drive you toward eating. If you’re using peptides that stimulate growth hormone release (rather than synthetic HGH itself), some of them act through ghrelin pathways and can meaningfully increase appetite.
Even with direct HGH injections, the metabolic changes described above, particularly the rapid mobilization of fat stores and the resulting insulin fluctuations, can create periods of increased hunger. If you’re eating more without realizing it, that caloric surplus will show up on the scale as genuine fat gain layered on top of the fluid retention.
Thyroid Hormone Interactions
HGH accelerates the conversion of T4 (the inactive storage form of thyroid hormone) into T3 (the active form that drives metabolism). This effect is dose-dependent, and resting energy expenditure increases along with T3 levels. On the surface, this should help with weight management, not hurt it.
The problem arises if you had borderline low thyroid function before starting HGH. By pulling more T4 into the T3 conversion pathway, HGH can deplete your T4 reserves and unmask a thyroid deficiency that wasn’t clinically apparent before. If your thyroid can’t keep up with the increased demand for T4 production, you end up with low overall thyroid output despite initially higher T3 levels. The result is a slower metabolism, fatigue, and weight gain that compounds the fluid retention. This is one reason thyroid function is often monitored alongside HGH therapy.
What the Weight Gain Timeline Tells You
The timing of your weight gain offers the clearest clue about its cause:
- First 1 to 4 weeks: Almost certainly fluid. Extracellular water expands rapidly once sodium reabsorption kicks in. Weight increases of 3 to 6 pounds in this window are typical and not a sign of fat gain.
- Months 1 to 3: A mix of continued fluid retention, early lean tissue changes, and potential appetite-driven caloric surplus. Fat loss from visceral stores is beginning but may not offset the scale increase yet.
- Months 3 to 6: Body composition shifts become more apparent. Subcutaneous and visceral fat continue declining in a dose-dependent fashion. If the scale is still climbing at this point, insulin resistance, increased caloric intake, or thyroid suppression are more likely contributors than fluid alone.
Dose Matters More Than You Think
Interestingly, a large safety review of over 15,800 patients found that peripheral edema rates were actually higher in patients on lower daily doses (0.30 mg/day or less) than in those on higher doses. This likely reflects the fact that lower-dose patients were older or had more comorbidities, but it underscores that the relationship between dose and side effects isn’t always linear.
What is clearly dose-dependent is the magnitude of body composition change. Higher doses produce greater lean mass gains and greater fat loss, but they also produce greater fluid retention and more insulin resistance. In young, healthy adults given supraphysiological doses (0.1 to 0.2 IU/kg/day), fluid retention symptoms occurred in the majority of participants, and IGF-1 levels jumped by 134% in a single month. For context, therapeutic replacement doses in adults with deficiency are far lower, typically 0.2 to 0.5 mg per day regardless of body weight, yet even these can produce noticeable fluid shifts in the early weeks.
If your weight gain is bothersome and persistent, a dose reduction often resolves the fluid component without sacrificing the longer-term fat loss and lean tissue benefits. Reducing sodium intake can also help counteract the kidney’s increased drive to hold onto salt.